| Dr Patricia Cucci, MD | |
|
1005 Clifton Ave, Clifton, NJ 07013-3520 | |
| (973) 472-4114 | |
| (973) 472-0775 |
| Full Name | Dr Patricia Cucci |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 1005 Clifton Ave, Clifton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538135231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 59376 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Retinal Consultants Llc | 2961509161 | 114 |
News Archive
Acorda Therapeutics, Inc. today announced an analysis of pooled clinical trial results showed patients who were responders to AMPYRA (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.
The public debate on endocrine disrupting chemicals- exogenous substances that have the same or similar effects as endogenous hormones - has been going on for some time.
Medical professionals have announced the need to change treatment of elderly patients in cardiac intensive care units.
Tennessee wants to be the first state to test a radical approach for federal financing of Medicaid, the federal-state health care program for low-income people.
University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
› Verified 9 days ago
| Entity Name | Associated Retinal Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164578894 PECOS PAC ID: 2961509161 Enrollment ID: O20070523000337 |
News Archive
Acorda Therapeutics, Inc. today announced an analysis of pooled clinical trial results showed patients who were responders to AMPYRA (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.
The public debate on endocrine disrupting chemicals- exogenous substances that have the same or similar effects as endogenous hormones - has been going on for some time.
Medical professionals have announced the need to change treatment of elderly patients in cardiac intensive care units.
Tennessee wants to be the first state to test a radical approach for federal financing of Medicaid, the federal-state health care program for low-income people.
University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia Cucci, MD 1005 Clifton Ave, Clifton, NJ 07013-3520 Ph: (973) 472-4114 | Dr Patricia Cucci, MD 1005 Clifton Ave, Clifton, NJ 07013-3520 Ph: (973) 472-4114 |
News Archive
Acorda Therapeutics, Inc. today announced an analysis of pooled clinical trial results showed patients who were responders to AMPYRA (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.
The public debate on endocrine disrupting chemicals- exogenous substances that have the same or similar effects as endogenous hormones - has been going on for some time.
Medical professionals have announced the need to change treatment of elderly patients in cardiac intensive care units.
Tennessee wants to be the first state to test a radical approach for federal financing of Medicaid, the federal-state health care program for low-income people.
University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
› Verified 9 days ago
Sierra Jin, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1016 Main Ave, Clifton, NJ 07011 Phone: 973-546-5700 | |
Alessandra Bertolucci, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1033 Clifton Ave Ste 107, Clifton, NJ 07013 Phone: 973-773-9882 Fax: 973-773-9883 | |
Dr. Michael L Mund, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1187 Main Ave, Ste. 1f, Clifton, NJ 07011 Phone: 973-546-6161 Fax: 973-546-1708 | |
Dr. Cecily Lesko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1005 Clifton Ave, Clifton, NJ 07013 Phone: 973-472-4114 Fax: 973-472-0775 | |
Khelly Savant, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1016 Main Ave, Clifton, NJ 07011 Phone: 973-546-5700 | |
Dr. Palak Majmudar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1005 Clifton Ave, Clifton, NJ 07013 Phone: 973-472-4114 |